You are viewing a free summary from Descrybe.ai. For citation checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.

Moore v. Regents of University of California

Citations: 793 P.2d 479; 51 Cal. 3d 120; 271 Cal. Rptr. 146; 15 U.S.P.Q. 2d (BNA) 1753; 16 A.L.R. 5th 903; 1990 Cal. LEXIS 2858Docket: S006987

Court: California Supreme Court; July 9, 1990; California; State Supreme Court

Narrative Opinion Summary

The case involves a plaintiff who brought a lawsuit against a university and associated parties, claiming unauthorized use of his cells for profitable research without informed consent. The core issue revolves around the breach of fiduciary duty by the plaintiff's physician, who failed to disclose financial and research interests before obtaining consent for medical procedures related to the plaintiff's treatment for leukemia. The California Supreme Court ruled that while the allegations support a cause of action for breach of fiduciary duty and lack of informed consent due to undisclosed interests, they do not sustain a conversion claim. The court emphasized that existing legal frameworks, such as fiduciary duty and informed consent, suffice to protect patients' rights without extending property rights to excised cells. The court also highlighted policy considerations, noting the potential impact on medical research if conversion liability were recognized. Ultimately, the court permitted the plaintiff to amend claims against certain defendants but sustained the demurrers regarding conversion without leave to amend, emphasizing that legislative action is better suited to address the complex issues surrounding ownership of human biological materials.

Legal Issues Addressed

Breach of Fiduciary Duty and Informed Consent

Application: The physician failed to disclose personal research and financial interests when obtaining consent for medical procedures, constituting a breach of fiduciary duty and lack of informed consent.

Reasoning: Moore's allegations against Golde centered on his failure to adequately disclose his research and financial interests in relation to Moore's cells prior to obtaining consent for medical procedures.

Conversion of Human Biological Materials

Application: The court concluded that human cells removed during medical procedures do not constitute property subject to conversion claims under existing law.

Reasoning: The court considers whether Moore's claim for conversion—a tort requiring proof of ownership or right to possession—can be substantiated under existing law. It concludes that it cannot, as Moore did not expect to retain possession of the cells post-removal and lacks evidence of ownership interest.

Legislative Framework Governing Human Biological Materials

Application: Existing statutes focus on regulatory management of human biological materials rather than classifying them as personal property, limiting claims for conversion.

Reasoning: Specialized statutes govern the disposition of human biological materials rather than the law of conversion.

Ownership and Property Rights in Human Cells

Application: The court ruled that Moore lacks ownership rights over cells once removed, as they are not treated as personal property under California law.

Reasoning: Several factors undermine his claim: precedent does not support such ownership, California law limits a patient's interest in excised cells, and the patented materials derived from the cells cannot be owned by Moore.

Patient's Right to Informed Decision-Making

Application: Physicians must disclose any personal interests that could affect medical judgment, thereby fulfilling fiduciary duties and ensuring informed consent.

Reasoning: The law acknowledges that patients deserve transparency regarding any potential profit motives that might impact their physician's decisions.